Clinical Trial Update: SWOG-9321 Melphalan, TBI, and Transplant vs Combo Chemo in Untreated Myeloma [Phase 3]

View source ↗

Summary

The Phase 3 SWOG-9321 trial comparing high-dose melphalan with total body irradiation and transplant versus combination chemotherapy in untreated multiple myelo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Melphalan (Melphalan)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED